Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,742,259
+$11,008,462 QoQ
Shares Held
376,777
+86.7% QoQ
Ownership
0.389%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#57
of 314 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Derivatives in XENE
reported options exposure · as of Sep 30, 2025CallValue
$2,609,750
CallShares
65,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,596,585,112 across 322 Biotechnology names. XENE ranks #45 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in XENE
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,742,259 | 376,777 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,733,797 | 201,785 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $28,463,209 | 635,056 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,609,750 | 65,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $55,567,881 | 1,384,007 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $27,632,735 | 882,835 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,852,578 | 234,056 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,564,768 | 346,040 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,229,353 | 209,026 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,846,020 | 175,584 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,601,606 | 83,661 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,545,007 | 76,965 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,537,200 | 45,000 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $3,262,040 | 95,493 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $341,600 | 10,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $8,213,513 | 213,338 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,926,411 | 221,470 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $23,442,751 | 594,541 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $20,228,598 | 560,349 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,987,660 | 492,691 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,167,485 | 136,326 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,831,000 | 90,621 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,609,426 | 236,219 | Shares | Sole | 2021-11-15 | |
| 2021-09-30 | $687,600 | 45,000 | Put | Sole | 2021-11-15 | |
| 2021-09-30 | $229,200 | 15,000 | Call | Sole | 2021-11-15 | |
| 2021-06-30 | $5,618,547 | 301,748 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,137,892 | 342,899 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,405,385 | 416,475 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,315,614 | 118,845 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,106,669 | 167,996 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,195,072 | 193,569 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||